Back to trial

NCT03283384

Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer.

Version 3 to 4 · Borstkanker Onderzoek Groep

Patch inspector

Version 3 to 4

71 operations 8 path groups ctgov_internal_history
ClinicalTrials.gov
Severity is deterministic uncalibrated triage metadata, not validated review priority. Operation-level severity is inferred from deterministic path rules. Rule matches shown per operation are approximate previews (they skip the pipeline's suppression passes); the authoritative classification is the stored event record.
Plain-language summary

Manual review pending.

Rules fired
arms_or_interventions_changecontact_admin_changeeligibility_criteria_changeprimary_outcome_any_changesecondary_outcome_any_change
Value signals
[
  {
    "path": "/protocolSection/statusModule/startDateStruct/date",
    "signal": "timeline_major_slip",
    "category": "timeline_major_slip",
    "new_type": "ACTUAL",
    "old_type": "ESTIMATED",
    "severity": "medium",
    "direction": "later",
    "new_value": "2019-06-15",
    "old_value": "2018-05",
    "delta_days": 410,
    "date_struct": "startDateStruct",
    "new_precision": "day",
    "old_precision": "month"
  },
  {
    "path": "/protocolSection/statusModule/primaryCompletionDateStruct/date",
    "signal": "timeline_significant_shift",
    "category": "timeline_significant_shift",
    "new_type": "ESTIMATED",
    "old_type": "ESTIMATED",
    "severity": "medium",
    "direction": "later",
    "new_value": "2021-01",
    "old_value": "2020-07",
    "delta_days": 184,
    "date_struct": "primaryCompletionDateStruct",
    "new_precision": "month",
    "old_precision": "month"
  },
  {
    "path": "/protocolSection/statusModule/completionDateStruct/date",
    "signal": "timeline_significant_shift",
    "category": "timeline_significant_shift",
    "new_type": "ESTIMATED",
    "old_type": "ESTIMATED",
    "severity": "medium",
    "direction": "later",
    "new_value": "2025-08",
    "old_value": "2025-02",
    "delta_days": 181,
    "date_struct": "completionDateStruct",
    "new_precision": "month",
    "old_precision": "month"
  }
]
Provenance
Source
ctgov_internal_history
Fetched
2026-06-18 19:11:34+00
Raw hash
ded7490b2b93d10b83ac8a6e4628f83f493c37c8850c444a0a10368011fdaf0d
Payload
Source URL
Primary outcomes Outcome measures that define the trial's primary evidence target. Triage: Critical 1 ops
replace /protocolSection/outcomesModule/primaryOutcomes/0/description
Triage: Critical
Primary Outcome Change Operation 10
Matched rules
  • primary_outcome_any_change Any add/remove/replace under primary outcome measures is critical review priority.
Before
Determine if ribociclib plus letrozole gives a >50% improvement in CCCA as compared to chemotherapy in the surgical specimen.
After
Determine if ribociclib plus letrozole gives a ≥100% improvement in CCCA as compared to chemotherapy in the surgical specimen.
Design Trial model, phase, allocation, masking, arms, or interventions. Triage: High 1 ops
replace /protocolSection/armsInterventionsModule/interventions/1/description
Triage: High
Arm Intervention Change Operation 9
Matched rules
  • arms_or_interventions_change Arms or interventions changes can alter treatment/comparator structure.
Before
AC-T chemotherapy: 4 cycles of AC (doxorubicin and cyclophosphamide at a dose of 60 and 600 mg/m² as an i.v.
bolus, respectively) 3-weekly, followed by cycles of T (4 cycles docetaxel 100 mg/m² 3-weekly or 12 cycles paclitaxel 80 mg/m² weekly).
After
Dose dense AC-T chemotherapy: consisting of 4 cycles of AC (doxorubicin and cyclophosphamide at a dose of 60 and 600 mg/m² as an i.v.
bolus, respectively) 2-weekly, plus G-CSF (6 mg once per cycle) 24-48 hr after chemotherapy, followed by cycles of T (4 cycles docetaxel 100 mg/m² 3-weekly or 12 cycles paclitaxel 80 mg/m2 weekly).
Eligibility Criteria and population definition changes. Triage: High 1 ops
replace /protocolSection/eligibilityModule/eligibilityCriteria
Triage: High
Eligibility Change Operation 13
Matched rules
  • eligibility_criteria_change Eligibility criteria changes can alter the studied population.
Before
<p>Inclusion Criteria:</p><ul><li>Postmenopausal women presenting with histological proven (core biopsy material) hormone receptor positive (ER&gt;50%, PR any), HER2 negative, stage II&#x2F; III breast cancer.</li><li>Measurable disease (breast and&#x2F;or lymph nodes)</li><li>WHO 0-2</li><li>Adequate bone marrow function (within 4 weeks prior to registration): WBC≥3.0x109&#x2F;l,
neutrophils ≥1.5 x 109&#x2F;l, platelets ≥100 x 109&#x2F;l</li><li>Adequate liver function (within 4 weeks prior to registration): bilirubin ≤1.5 x upper limit of normal (UNL) range, ALAT and&#x2F;or ASAT ≤2.5 x UNL, Alkaline Phosphatase ≤5 x UNL</li><li>Adequate renal function (within 4 weeks prior to registration): the calculated creatinine clearance should be ≥50 ml&#x2F;min</li><li>Accessible for treatment and follow-up</li><li>Written informed consent</li></ul><p>Inclusion criteria randomization specific:</p><p>In order to be eligible to be randomized in this study, a subject must meet all of the following criteria:</p><ul><li>Registration in the NEOLBC trial before start of letrozole</li><li>Use of letrozole</li><li>Outcome central Ki67 determination in two weeks biopsy available.</li></ul><p>Exclusion Criteria:</p><ul><li>Evidence of distant metastases (M1)</li><li>Previous invasive breast cancer</li><li>Prior chemotherapy, hormonal therapy or radiation therapy</li><li>Previous malignancy within 5 years, with exception of a history of a previous basal cell carcinoma of the skin or pre-invasive carcinoma of the cervix.</li><li>Peripheral neuropathy &gt; grade 2, whatever the cause</li><li>Serious other diseases as infections (hepatitis B, C and HIV), recent myocardial infarction, clinical signs of cardiac failure or clinically significant arrhythmias or on screening, any of the following cardiac parameters: bradycardia (heart rate &lt;50 at rest), tachycardia (heart rate &gt; 90 at rest), PR interval &gt; 220 msec, QRS interval &gt;109 msec, or QTcF &gt;450 msec.</li><li>Known hypersensitivity reaction to any of the components of the treatment</li><li>Currently receiving warfarin or other coumarin derived anti-coagulant, for treatment, prophylaxis or otherwise.
Therapy with heparin, low molecular weight heparin (LMWH), or fondaparinux is allowed.</li><li><p>Currently receiving any of the following substances and cannot be discontinued 7 days prior to randomisation:</p><ul><li>Known strong inducers or inhibitors of CYP3A4&#x2F;5, including grapefruit, grapefruit hybrids, pummelo&#x27;s, star-fruit, and Seville oranges.</li><li>That have a known risk to prolong the QT interval or induce Torsades de Pointes.</li><li>That have a narrow therapeutic window and are predominantly metabolized through CYP3A4&#x2F;5.</li><li>Herbal preparations&#x2F;medications, dietary supplements.</li></ul></li><li>Medical or psychological condition which in the opinion of the investigator would not permit the patient to complete the study or sign meaningful informed consent.</li></ul>
After
<p>Inclusion Criteria:</p><ul><li>Postmenopausal women presenting with histological proven (core biopsy material) hormone receptor positive (ER≥50%, PR any), HER2 negative, stage II&#x2F; III breast cancer.</li><li>Measurable disease (breast and&#x2F;or lymph nodes)</li><li>WHO 0-2</li><li>Adequate bone marrow function (within 4 weeks prior to registration): WBC≥3.0x109&#x2F;l,
neutrophils ≥1.5 x 109&#x2F;l, platelets ≥100 x 109&#x2F;l</li><li>Adequate liver function (within 4 weeks prior to registration): bilirubin ≤1.5 x upper limit of normal (UNL) range, ALAT and&#x2F;or ASAT ≤2.5 x UNL, Alkaline Phosphatase ≤5 x UNL</li><li>Adequate renal function (within 4 weeks prior to registration): the calculated creatinine clearance should be ≥50 ml&#x2F;min</li><li>Accessible for treatment and follow-up</li><li>Written informed consent</li></ul><p>Inclusion criteria randomization specific:</p><p>In order to be eligible to be randomized in this study, a subject must meet all of the following criteria:</p><ul><li>Registration in the NEOLBC trial before 2 weeks biopsy</li><li>Use of letrozole</li><li>Outcome central Ki67 determination in two weeks biopsy available.</li></ul><p>Exclusion Criteria:</p><ul><li>Evidence of distant metastases (M1)</li><li>Previous invasive breast cancer</li><li>Prior chemotherapy, radiation therapy or hormonal therapy with the exception of patients who received letrozole ≤ 14 days (+ max. 4 days) prior to registration and who are still on letrozole.</li><li>Previous malignancy within 5 years, with exception of a history of a previous basal cell carcinoma of the skin or pre-invasive carcinoma of the cervix.</li><li>Peripheral neuropathy &gt; grade 2, whatever the cause</li><li>Serious other diseases as infections (hepatitis B, C and HIV), recent myocardial infarction, clinical signs of cardiac failure or clinically significant arrhythmias or on screening, any of the following cardiac parameters: bradycardia (heart rate &lt;50 at rest) or QTcF ≥450 msec.</li><li>Known hypersensitivity reaction to any of the components of the treatment (peanuts, soy)</li><li>Currently receiving warfarin or other coumarin derived anti-coagulant, for treatment, prophylaxis or otherwise.
Therapy with heparin, low molecular weight heparin (LMWH), or fondaparinux is allowed.</li><li><p>Currently receiving any of the following substances and cannot be discontinued 7 days prior to randomisation:</p><ul><li>Known strong inducers or inhibitors of CYP3A4&#x2F;5, including grapefruit, grapefruit hybrids, pummelo&#x27;s, star-fruit, pomegranate and Seville oranges.</li><li>That have a known risk to prolong the QT interval or induce Torsades de Pointes.</li><li>That have a narrow therapeutic window and are predominantly metabolized through CYP3A4&#x2F;5.</li><li>Herbal preparations&#x2F;medications, dietary supplements.</li></ul></li><li>Medical or psychological condition which in the opinion of the investigator would not permit the patient to complete the study or sign meaningful informed consent.</li></ul>
Secondary outcomes Additional endpoints and outcome descriptions. Triage: High 2 ops
replace /protocolSection/outcomesModule/secondaryOutcomes/5/measure
Triage: High
Secondary Outcome Change Operation 11
Matched rules
  • secondary_outcome_any_change Any add/remove/replace under secondary outcome measures is high review priority.
Before
Correlation of tumor measurements between standard MRI (using RECIST 1.1) and palpation (largest diameter in cm) at baseline, after 12 weeks of therapy and pre-surgery.
After
Correlation of tumor measurements between standard MRI (using RECIST 1.1) and palpation (largest diameter in cm) at baseline, after AC&#x2F;before T or 8 weeks of definitive neoadjuvant therapy and pre-surgery.
replace /protocolSection/outcomesModule/secondaryOutcomes/5/timeFrame
Triage: High
Secondary Outcome Change Operation 12
Matched rules
  • secondary_outcome_any_change Any add/remove/replace under secondary outcome measures is high review priority.
Before
Tumor measurements (MRI and palpation) will be performed at baseline, after 12 weeks of therapy and pre-surgery (which is around 7 months after start of initial letrozole treatment).
After
Tumor measurements (MRI and palpation) will be performed at baseline, after AC&#x2F;before T or 8 weeks of definitive neoadjuvant therapy and pre-surgery (which is around 7 months after start of initial letrozole treatment).
Timeline Start, primary completion, and completion date movement. Triage: Medium 4 ops
replace /protocolSection/statusModule/startDateStruct/date
Triage: Medium
Timeline Shift Operation 2
Matched rules
  • start_timeline_change Start date changes are operational timeline signals.
Before
2018-05
After
2019-06-15
replace /protocolSection/statusModule/startDateStruct/type
Triage: Medium
Timeline Shift Operation 3
Matched rules
  • start_timeline_change Start date changes are operational timeline signals.
Before
ESTIMATED
After
ACTUAL
replace /protocolSection/statusModule/primaryCompletionDateStruct/date
Triage: Medium
Timeline Shift Operation 4
Matched rules
  • primary_completion_timeline_change Primary completion date changes are operational timeline signals.
Before
2020-07
After
2021-01
replace /protocolSection/statusModule/completionDateStruct/date
Triage: Medium
Timeline Shift Operation 5
Matched rules
  • completion_timeline_change Completion date changes are operational timeline signals.
Before
2025-02
After
2025-08
Contacts and locations Site, contact, and location updates that are usually operational. Triage: Low 58 ops
replace /protocolSection/contactsLocationsModule/centralContacts/1/phone
Triage: Low
Administrative Contact Change Operation 14
Matched rules
  • contact_admin_change Central contact updates are usually administrative.
Before
+31715261032
After
+31715299126
replace /protocolSection/contactsLocationsModule/locations/1/facility
Triage: Uncategorized
Uncategorized Operation 15
Before
Ziekenhuisgroep Twente (Twenteborg ZH Almelo)
After
Ziekenhuisgroep Twente
replace /protocolSection/contactsLocationsModule/locations/3/status
Triage: Uncategorized
Uncategorized Operation 16
Before
NOT_YET_RECRUITING
After
RECRUITING
replace /protocolSection/contactsLocationsModule/locations/4/facility
Triage: Uncategorized
Uncategorized Operation 17
Before
Onze Lieve Vrouwe Gasthuis (Oost)
After
Onze Lieve Vrouwe Gasthuis
replace /protocolSection/contactsLocationsModule/locations/4/contacts/0/name
Triage: Uncategorized
Uncategorized Operation 18
Before
J. Meerum Terwogt
After
E. Kerver
replace /protocolSection/contactsLocationsModule/locations/5/facility
Triage: Uncategorized
Uncategorized Operation 19
Before
Stichting Reinier Haga Groep (Reinier de Graaf Gasthuis)
After
Gelre Ziekenhuizen
replace /protocolSection/contactsLocationsModule/locations/5/city
Triage: Uncategorized
Uncategorized Operation 20
Before
Delft
After
Apeldoorn
replace /protocolSection/contactsLocationsModule/locations/5/contacts/0/name
Triage: Uncategorized
Uncategorized Operation 21
Before
K. Beelen
After
S. Tromp - van Driel
replace /protocolSection/contactsLocationsModule/locations/5/geoPoint/lat
Triage: Uncategorized
Uncategorized Operation 22
Before
52.00667
After
52.21
replace /protocolSection/contactsLocationsModule/locations/5/geoPoint/lon
Triage: Uncategorized
Uncategorized Operation 23
Before
4.35556
After
5.96944
replace /protocolSection/contactsLocationsModule/locations/6/facility
Triage: Uncategorized
Uncategorized Operation 24
Before
Stichting Deventer Ziekenhuisgroep Rielerenk
After
Amphia Ziekenhuis
replace /protocolSection/contactsLocationsModule/locations/6/status
Triage: Uncategorized
Uncategorized Operation 25
Before
NOT_YET_RECRUITING
After
RECRUITING
replace /protocolSection/contactsLocationsModule/locations/6/city
Triage: Uncategorized
Uncategorized Operation 26
Before
Deventer
After
Breda
replace /protocolSection/contactsLocationsModule/locations/6/contacts/0/name
Triage: Uncategorized
Uncategorized Operation 27
Before
L. Kessels
After
J. Heijns
replace /protocolSection/contactsLocationsModule/locations/6/geoPoint/lat
Triage: Uncategorized
Uncategorized Operation 28
Before
52.255
After
51.58656
replace /protocolSection/contactsLocationsModule/locations/6/geoPoint/lon
Triage: Uncategorized
Uncategorized Operation 29
Before
6.16389
After
4.77596
add /protocolSection/contactsLocationsModule/locations/7
Triage: Uncategorized
Uncategorized Operation 30
After
{
  "city": "Delft",
  "status": "NOT_YET_RECRUITING",
  "country": "Netherlands",
  "contacts": [
    {
      "name": "M. van Bekkum",
      "role": "CONTACT"
    }
  ],
  "facility": "Stichting Reinier Haga Groep (Reinier de Graaf Gasthuis)",
  "geoPoint": {
    "lat": 52.00667,
    "lon": 4.35556
  }
}
add /protocolSection/contactsLocationsModule/locations/8
Triage: Uncategorized
Uncategorized Operation 31
After
{
  "city": "Deventer",
  "status": "RECRUITING",
  "country": "Netherlands",
  "contacts": [
    {
      "name": "L. Kessels",
      "role": "CONTACT"
    }
  ],
  "facility": "Stichting Deventer Ziekenhuisgroep",
  "geoPoint": {
    "lat": 52.255,
    "lon": 6.16389
  }
}
replace /protocolSection/contactsLocationsModule/locations/10/facility
Triage: Uncategorized
Uncategorized Operation 32
Before
Maxima Medisch Centrum (Eindhoven)
After
Maxima Medisch Centrum
replace /protocolSection/contactsLocationsModule/locations/11/facility
Triage: Uncategorized
Uncategorized Operation 33
Before
Groene Hart Ziekenhuis (Bleuland)
After
Groene Hart Ziekenhuis
replace /protocolSection/contactsLocationsModule/locations/11/status
Triage: Uncategorized
Uncategorized Operation 34
Before
NOT_YET_RECRUITING
After
RECRUITING
replace /protocolSection/contactsLocationsModule/locations/12/facility
Triage: Uncategorized
Uncategorized Operation 35
Before
Spaarne Gasthuis (Haarlem-Zuid)
After
Spaarne Gasthuis
replace /protocolSection/contactsLocationsModule/locations/13/status
Triage: Uncategorized
Uncategorized Operation 36
Before
NOT_YET_RECRUITING
After
RECRUITING
replace /protocolSection/contactsLocationsModule/locations/14/facility
Triage: Uncategorized
Uncategorized Operation 37
Before
Tergooiziekenhuizen (Hilversum)
After
Tergooi Ziekenhuizen
replace /protocolSection/contactsLocationsModule/locations/14/status
Triage: Uncategorized
Uncategorized Operation 38
Before
NOT_YET_RECRUITING
After
RECRUITING
replace /protocolSection/contactsLocationsModule/locations/18/status
Triage: Uncategorized
Uncategorized Operation 39
Before
NOT_YET_RECRUITING
After
RECRUITING
replace /protocolSection/contactsLocationsModule/locations/19/facility
Triage: Uncategorized
Uncategorized Operation 40
Before
Bravis Ziekenhuis (Roosendaal)
After
Laurentius Ziekenhuis
replace /protocolSection/contactsLocationsModule/locations/19/city
Triage: Uncategorized
Uncategorized Operation 41
Before
Roosendaal
After
Roermond
replace /protocolSection/contactsLocationsModule/locations/19/contacts/0/name
Triage: Uncategorized
Uncategorized Operation 42
Before
H. Droogendijk
After
K. Aaldering
replace /protocolSection/contactsLocationsModule/locations/19/geoPoint/lat
Triage: Uncategorized
Uncategorized Operation 43
Before
51.53083
After
51.19417
replace /protocolSection/contactsLocationsModule/locations/19/geoPoint/lon
Triage: Uncategorized
Uncategorized Operation 44
Before
4.46528
After
5.9875
replace /protocolSection/contactsLocationsModule/locations/20/facility
Triage: Uncategorized
Uncategorized Operation 45
Before
Antonius Ziekenhuis Sneek
After
Bravis Ziekenhuis
replace /protocolSection/contactsLocationsModule/locations/20/city
Triage: Uncategorized
Uncategorized Operation 46
Before
Sneek
After
Roosendaal
replace /protocolSection/contactsLocationsModule/locations/20/contacts/0/name
Triage: Uncategorized
Uncategorized Operation 47
Before
G. Veldhuis
After
H. Droogendijk
replace /protocolSection/contactsLocationsModule/locations/20/geoPoint/lat
Triage: Uncategorized
Uncategorized Operation 48
Before
53.03297
After
51.53083
replace /protocolSection/contactsLocationsModule/locations/20/geoPoint/lon
Triage: Uncategorized
Uncategorized Operation 49
Before
5.6589
After
4.46528
add /protocolSection/contactsLocationsModule/locations/21
Triage: Uncategorized
Uncategorized Operation 50
After
{
  "city": "Rotterdam",
  "status": "NOT_YET_RECRUITING",
  "country": "Netherlands",
  "contacts": [
    {
      "name": "A. Jager",
      "role": "CONTACT"
    }
  ],
  "facility": "Erasmus MC, Universitair Medisch Centrum Rotterdam",
  "geoPoint": {
    "lat": 51.9225,
    "lon": 4.47917
  }
}
add /protocolSection/contactsLocationsModule/locations/22
Triage: Uncategorized
Uncategorized Operation 51
After
{
  "city": "Sneek",
  "status": "NOT_YET_RECRUITING",
  "country": "Netherlands",
  "contacts": [
    {
      "name": "G. Veldhuis",
      "role": "CONTACT"
    }
  ],
  "facility": "Antonius Ziekenhuis",
  "geoPoint": {
    "lat": 53.03297,
    "lon": 5.6589
  }
}
add /protocolSection/contactsLocationsModule/locations/23
Triage: Uncategorized
Uncategorized Operation 52
After
{
  "city": "The Hague",
  "status": "RECRUITING",
  "country": "Netherlands",
  "contacts": [
    {
      "name": "H. Oosterkamp",
      "role": "CONTACT"
    }
  ],
  "facility": "Haaglanden Medisch Centrum",
  "geoPoint": {
    "lat": 52.07667,
    "lon": 4.29861
  }
}
add /protocolSection/contactsLocationsModule/locations/24
Triage: Uncategorized
Uncategorized Operation 53
After
{
  "city": "The Hague",
  "status": "RECRUITING",
  "country": "Netherlands",
  "contacts": [
    {
      "name": "D. Houtsma",
      "role": "CONTACT"
    }
  ],
  "facility": "HAGA Ziekenhuis",
  "geoPoint": {
    "lat": 52.07667,
    "lon": 4.29861
  }
}
replace /protocolSection/contactsLocationsModule/locations/26/facility
Triage: Uncategorized
Uncategorized Operation 54
Before
VieCuri Medisch Centrum (Venlo)
After
Elisabeth Tweesteden Ziekenhuis
replace /protocolSection/contactsLocationsModule/locations/26/city
Triage: Uncategorized
Uncategorized Operation 55
Before
Venlo
After
Tilburg
replace /protocolSection/contactsLocationsModule/locations/26/contacts/0/name
Triage: Uncategorized
Uncategorized Operation 56
Before
A. van de Wouw
After
J. van Riel
replace /protocolSection/contactsLocationsModule/locations/26/geoPoint/lat
Triage: Uncategorized
Uncategorized Operation 57
Before
51.37
After
51.55551
replace /protocolSection/contactsLocationsModule/locations/26/geoPoint/lon
Triage: Uncategorized
Uncategorized Operation 58
Before
6.16806
After
5.0913
replace /protocolSection/contactsLocationsModule/locations/27/facility
Triage: Uncategorized
Uncategorized Operation 59
Before
Streekziekenhuis Koningin Beatrix
After
VieCuri Medisch Centrum
replace /protocolSection/contactsLocationsModule/locations/27/status
Triage: Uncategorized
Uncategorized Operation 60
Before
NOT_YET_RECRUITING
After
RECRUITING
replace /protocolSection/contactsLocationsModule/locations/27/city
Triage: Uncategorized
Uncategorized Operation 61
Before
Winterswijk
After
Venlo
replace /protocolSection/contactsLocationsModule/locations/27/contacts/0/name
Triage: Uncategorized
Uncategorized Operation 62
Before
P. Schiphorst
After
A. van de Wouw
replace /protocolSection/contactsLocationsModule/locations/27/geoPoint/lat
Triage: Uncategorized
Uncategorized Operation 63
Before
51.9725
After
51.37
replace /protocolSection/contactsLocationsModule/locations/27/geoPoint/lon
Triage: Uncategorized
Uncategorized Operation 64
Before
6.71944
After
6.16806
replace /protocolSection/contactsLocationsModule/locations/28/facility
Triage: Uncategorized
Uncategorized Operation 65
Before
Isala (Zwolle)
After
Streekziekenhuis Koningin Beatrix
replace /protocolSection/contactsLocationsModule/locations/28/status
Triage: Uncategorized
Uncategorized Operation 66
Before
NOT_YET_RECRUITING
After
RECRUITING
replace /protocolSection/contactsLocationsModule/locations/28/city
Triage: Uncategorized
Uncategorized Operation 67
Before
Zwolle
After
Winterswijk
replace /protocolSection/contactsLocationsModule/locations/28/contacts/0/name
Triage: Uncategorized
Uncategorized Operation 68
Before
A. Honkoop
After
P. Schiphorst
replace /protocolSection/contactsLocationsModule/locations/28/geoPoint/lat
Triage: Uncategorized
Uncategorized Operation 69
Before
52.5125
After
51.9725
replace /protocolSection/contactsLocationsModule/locations/28/geoPoint/lon
Triage: Uncategorized
Uncategorized Operation 70
Before
6.09444
After
6.71944
add /protocolSection/contactsLocationsModule/locations/29
Triage: Uncategorized
Uncategorized Operation 71
After
{
  "city": "Zwolle",
  "status": "NOT_YET_RECRUITING",
  "country": "Netherlands",
  "contacts": [
    {
      "name": "A. Honkoop",
      "role": "CONTACT"
    }
  ],
  "facility": "Isala",
  "geoPoint": {
    "lat": 52.5125,
    "lon": 6.09444
  }
}
Other registry fields Changes outside the current high-signal rule families. Triage: Uncategorized 3 ops
replace /protocolSection/statusModule/statusVerifiedDate
Triage: Uncategorized
Uncategorized Operation 1
Before
2018-05
After
2019-07
replace /protocolSection/statusModule/lastUpdateSubmitDate
Triage: Uncategorized
Uncategorized Operation 6
Before
2018-05-09
After
2019-07-22
replace /protocolSection/statusModule/lastUpdatePostDateStruct/date
Triage: Uncategorized
Uncategorized Operation 7
Before
2018-05-15
After
2019-07-23
Sponsor and administrative fields Sponsor, collaborator, oversight, or registry maintenance changes. Triage: Uncategorized 1 ops
remove /protocolSection/oversightModule/isUsExport
Triage: Uncategorized
Uncategorized Operation 8
Before
true
Raw JSON Patch
[
  {
    "op": "replace",
    "path": "/protocolSection/statusModule/statusVerifiedDate",
    "value": "2019-07"
  },
  {
    "op": "replace",
    "path": "/protocolSection/statusModule/startDateStruct/date",
    "value": "2019-06-15"
  },
  {
    "op": "replace",
    "path": "/protocolSection/statusModule/startDateStruct/type",
    "value": "ACTUAL"
  },
  {
    "op": "replace",
    "path": "/protocolSection/statusModule/primaryCompletionDateStruct/date",
    "value": "2021-01"
  },
  {
    "op": "replace",
    "path": "/protocolSection/statusModule/completionDateStruct/date",
    "value": "2025-08"
  },
  {
    "op": "replace",
    "path": "/protocolSection/statusModule/lastUpdateSubmitDate",
    "value": "2019-07-22"
  },
  {
    "op": "replace",
    "path": "/protocolSection/statusModule/lastUpdatePostDateStruct/date",
    "value": "2019-07-23"
  },
  {
    "op": "remove",
    "path": "/protocolSection/oversightModule/isUsExport"
  },
  {
    "op": "replace",
    "path": "/protocolSection/armsInterventionsModule/interventions/1/description",
    "value": "Dose dense AC-T chemotherapy: consisting of 4 cycles of AC (doxorubicin and cyclophosphamide at a dose of 60 and 600 mg&#x2F;m² as an i.v.\nbolus, respectively) 2-weekly, plus G-CSF (6 mg once per cycle) 24-48 hr after chemotherapy, followed by cycles of T (4 cycles docetaxel 100 mg&#x2F;m² 3-weekly or 12 cycles paclitaxel 80 mg&#x2F;m2 weekly)."
  },
  {
    "op": "replace",
    "path": "/protocolSection/outcomesModule/primaryOutcomes/0/description",
    "value": "Determine if ribociclib plus letrozole gives a ≥100% improvement in CCCA as compared to chemotherapy in the surgical specimen."
  },
  {
    "op": "replace",
    "path": "/protocolSection/outcomesModule/secondaryOutcomes/5/measure",
    "value": "Correlation of tumor measurements between standard MRI (using RECIST 1.1) and palpation (largest diameter in cm) at baseline, after AC&#x2F;before T or 8 weeks of definitive neoadjuvant therapy and pre-surgery."
  },
  {
    "op": "replace",
    "path": "/protocolSection/outcomesModule/secondaryOutcomes/5/timeFrame",
    "value": "Tumor measurements (MRI and palpation) will be performed at baseline, after AC&#x2F;before T or 8 weeks of definitive neoadjuvant therapy and pre-surgery (which is around 7 months after start of initial letrozole treatment)."
  },
  {
    "op": "replace",
    "path": "/protocolSection/eligibilityModule/eligibilityCriteria",
    "value": "<p>Inclusion Criteria:</p><ul><li>Postmenopausal women presenting with histological proven (core biopsy material) hormone receptor positive (ER≥50%, PR any), HER2 negative, stage II&#x2F; III breast cancer.</li><li>Measurable disease (breast and&#x2F;or lymph nodes)</li><li>WHO 0-2</li><li>Adequate bone marrow function (within 4 weeks prior to registration): WBC≥3.0x109&#x2F;l,\nneutrophils ≥1.5 x 109&#x2F;l, platelets ≥100 x 109&#x2F;l</li><li>Adequate liver function (within 4 weeks prior to registration): bilirubin ≤1.5 x upper limit of normal (UNL) range, ALAT and&#x2F;or ASAT ≤2.5 x UNL, Alkaline Phosphatase ≤5 x UNL</li><li>Adequate renal function (within 4 weeks prior to registration): the calculated creatinine clearance should be ≥50 ml&#x2F;min</li><li>Accessible for treatment and follow-up</li><li>Written informed consent</li></ul><p>Inclusion criteria randomization specific:</p><p>In order to be eligible to be randomized in this study, a subject must meet all of the following criteria:</p><ul><li>Registration in the NEOLBC trial before 2 weeks biopsy</li><li>Use of letrozole</li><li>Outcome central Ki67 determination in two weeks biopsy available.</li></ul><p>Exclusion Criteria:</p><ul><li>Evidence of distant metastases (M1)</li><li>Previous invasive breast cancer</li><li>Prior chemotherapy, radiation therapy or hormonal therapy with the exception of patients who received letrozole ≤ 14 days (+ max. 4 days) prior to registration and who are still on letrozole.</li><li>Previous malignancy within 5 years, with exception of a history of a previous basal cell carcinoma of the skin or pre-invasive carcinoma of the cervix.</li><li>Peripheral neuropathy &gt; grade 2, whatever the cause</li><li>Serious other diseases as infections (hepatitis B, C and HIV), recent myocardial infarction, clinical signs of cardiac failure or clinically significant arrhythmias or on screening, any of the following cardiac parameters: bradycardia (heart rate &lt;50 at rest) or QTcF ≥450 msec.</li><li>Known hypersensitivity reaction to any of the components of the treatment (peanuts, soy)</li><li>Currently receiving warfarin or other coumarin derived anti-coagulant, for treatment, prophylaxis or otherwise.\nTherapy with heparin, low molecular weight heparin (LMWH), or fondaparinux is allowed.</li><li><p>Currently receiving any of the following substances and cannot be discontinued 7 days prior to randomisation:</p><ul><li>Known strong inducers or inhibitors of CYP3A4&#x2F;5, including grapefruit, grapefruit hybrids, pummelo&#x27;s, star-fruit, pomegranate and Seville oranges.</li><li>That have a known risk to prolong the QT interval or induce Torsades de Pointes.</li><li>That have a narrow therapeutic window and are predominantly metabolized through CYP3A4&#x2F;5.</li><li>Herbal preparations&#x2F;medications, dietary supplements.</li></ul></li><li>Medical or psychological condition which in the opinion of the investigator would not permit the patient to complete the study or sign meaningful informed consent.</li></ul>"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/centralContacts/1/phone",
    "value": "+31715299126"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/1/facility",
    "value": "Ziekenhuisgroep Twente"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/3/status",
    "value": "RECRUITING"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/4/facility",
    "value": "Onze Lieve Vrouwe Gasthuis"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/4/contacts/0/name",
    "value": "E. Kerver"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/5/facility",
    "value": "Gelre Ziekenhuizen"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/5/city",
    "value": "Apeldoorn"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/5/contacts/0/name",
    "value": "S. Tromp - van Driel"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/5/geoPoint/lat",
    "value": 52.21
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/5/geoPoint/lon",
    "value": 5.96944
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/6/facility",
    "value": "Amphia Ziekenhuis"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/6/status",
    "value": "RECRUITING"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/6/city",
    "value": "Breda"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/6/contacts/0/name",
    "value": "J. Heijns"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/6/geoPoint/lat",
    "value": 51.58656
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/6/geoPoint/lon",
    "value": 4.77596
  },
  {
    "op": "add",
    "path": "/protocolSection/contactsLocationsModule/locations/7",
    "value": {
      "city": "Delft",
      "status": "NOT_YET_RECRUITING",
      "country": "Netherlands",
      "contacts": [
        {
          "name": "M. van Bekkum",
          "role": "CONTACT"
        }
      ],
      "facility": "Stichting Reinier Haga Groep (Reinier de Graaf Gasthuis)",
      "geoPoint": {
        "lat": 52.00667,
        "lon": 4.35556
      }
    }
  },
  {
    "op": "add",
    "path": "/protocolSection/contactsLocationsModule/locations/8",
    "value": {
      "city": "Deventer",
      "status": "RECRUITING",
      "country": "Netherlands",
      "contacts": [
        {
          "name": "L. Kessels",
          "role": "CONTACT"
        }
      ],
      "facility": "Stichting Deventer Ziekenhuisgroep",
      "geoPoint": {
        "lat": 52.255,
        "lon": 6.16389
      }
    }
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/10/facility",
    "value": "Maxima Medisch Centrum"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/11/facility",
    "value": "Groene Hart Ziekenhuis"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/11/status",
    "value": "RECRUITING"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/12/facility",
    "value": "Spaarne Gasthuis"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/13/status",
    "value": "RECRUITING"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/14/facility",
    "value": "Tergooi Ziekenhuizen"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/14/status",
    "value": "RECRUITING"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/18/status",
    "value": "RECRUITING"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/19/facility",
    "value": "Laurentius Ziekenhuis"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/19/city",
    "value": "Roermond"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/19/contacts/0/name",
    "value": "K. Aaldering"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/19/geoPoint/lat",
    "value": 51.19417
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/19/geoPoint/lon",
    "value": 5.9875
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/20/facility",
    "value": "Bravis Ziekenhuis"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/20/city",
    "value": "Roosendaal"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/20/contacts/0/name",
    "value": "H. Droogendijk"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/20/geoPoint/lat",
    "value": 51.53083
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/20/geoPoint/lon",
    "value": 4.46528
  },
  {
    "op": "add",
    "path": "/protocolSection/contactsLocationsModule/locations/21",
    "value": {
      "city": "Rotterdam",
      "status": "NOT_YET_RECRUITING",
      "country": "Netherlands",
      "contacts": [
        {
          "name": "A. Jager",
          "role": "CONTACT"
        }
      ],
      "facility": "Erasmus MC, Universitair Medisch Centrum Rotterdam",
      "geoPoint": {
        "lat": 51.9225,
        "lon": 4.47917
      }
    }
  },
  {
    "op": "add",
    "path": "/protocolSection/contactsLocationsModule/locations/22",
    "value": {
      "city": "Sneek",
      "status": "NOT_YET_RECRUITING",
      "country": "Netherlands",
      "contacts": [
        {
          "name": "G. Veldhuis",
          "role": "CONTACT"
        }
      ],
      "facility": "Antonius Ziekenhuis",
      "geoPoint": {
        "lat": 53.03297,
        "lon": 5.6589
      }
    }
  },
  {
    "op": "add",
    "path": "/protocolSection/contactsLocationsModule/locations/23",
    "value": {
      "city": "The Hague",
      "status": "RECRUITING",
      "country": "Netherlands",
      "contacts": [
        {
          "name": "H. Oosterkamp",
          "role": "CONTACT"
        }
      ],
      "facility": "Haaglanden Medisch Centrum",
      "geoPoint": {
        "lat": 52.07667,
        "lon": 4.29861
      }
    }
  },
  {
    "op": "add",
    "path": "/protocolSection/contactsLocationsModule/locations/24",
    "value": {
      "city": "The Hague",
      "status": "RECRUITING",
      "country": "Netherlands",
      "contacts": [
        {
          "name": "D. Houtsma",
          "role": "CONTACT"
        }
      ],
      "facility": "HAGA Ziekenhuis",
      "geoPoint": {
        "lat": 52.07667,
        "lon": 4.29861
      }
    }
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/26/facility",
    "value": "Elisabeth Tweesteden Ziekenhuis"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/26/city",
    "value": "Tilburg"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/26/contacts/0/name",
    "value": "J. van Riel"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/26/geoPoint/lat",
    "value": 51.55551
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/26/geoPoint/lon",
    "value": 5.0913
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/27/facility",
    "value": "VieCuri Medisch Centrum"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/27/status",
    "value": "RECRUITING"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/27/city",
    "value": "Venlo"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/27/contacts/0/name",
    "value": "A. van de Wouw"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/27/geoPoint/lat",
    "value": 51.37
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/27/geoPoint/lon",
    "value": 6.16806
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/28/facility",
    "value": "Streekziekenhuis Koningin Beatrix"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/28/status",
    "value": "RECRUITING"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/28/city",
    "value": "Winterswijk"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/28/contacts/0/name",
    "value": "P. Schiphorst"
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/28/geoPoint/lat",
    "value": 51.9725
  },
  {
    "op": "replace",
    "path": "/protocolSection/contactsLocationsModule/locations/28/geoPoint/lon",
    "value": 6.71944
  },
  {
    "op": "add",
    "path": "/protocolSection/contactsLocationsModule/locations/29",
    "value": {
      "city": "Zwolle",
      "status": "NOT_YET_RECRUITING",
      "country": "Netherlands",
      "contacts": [
        {
          "name": "A. Honkoop",
          "role": "CONTACT"
        }
      ],
      "facility": "Isala",
      "geoPoint": {
        "lat": 52.5125,
        "lon": 6.09444
      }
    }
  }
]